Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Medical Device Market Ripe For International Players, But Policy Obstacles Remain

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - The demand for medical devices in India is expected to exceed $5 billion by 2012, creating a major opportunity for multinational device makers

You may also be interested in...

Medical Device Market In India Heads Toward Boom; MNCs Control Majority Of High-end Market

MUMBAI - Growing investment in private sector infrastructure and increased healthcare funding from the government have led to a 15-20 percent rise in demand for medical devices and equipment in India

Drug Controller General Of India Surinder Singh On India’s Regulatory Overhaul: An Interview With PharmAsia News

Surinder Singh took the mantle of the Drug Controller General of India a few months ago. From being a microbiologist to handling the most important regulatory position in the Indian drug industry, Singh is already confronted with a host of challenges. Overhauling the regulatory system, dealing with vexatious registration issues and advocating for Indian drug industry on global forums, Singh has been working on an extremely tight schedule. Singh took time off from his busy routine and sat down with PharmAsia News' India bureau to discuss India's impending regulatory overhaul (PharmAsia News, Sept. 11, 2008).

Nicholas Piramal Launches U.S. Cleared Yoga-Inspired Device In India

NEW DELHI - Deep breathing exercises familiar to Americans at yoga gyms were the basis for the first U.S. FDA clearance of an over-the-counter medical device for adjunctive treatment of hypertension back in 2002 - a device that now may represent an important leap forward for India's struggling traditional healing product companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts